Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 16781-16790 Newer>

The Motley Fool September 11, 2006 Rick Aristotle Munarriz	A Visionary Lives On Akamai's Danny Lewin may have died on 9/11, but his vision proved true five years later. Five years ago, Akamai shares traded for less than $3. Today they closed at a five-year high, soaring roughly 15-fold in that time.
The Motley Fool September 11, 2006 Rich Smith	Lakeland Pleads for Patience Things may get better, later. The problem is that Lakeland investors have already been patient -- but with inventories still rising, sales again falling, and the share price down 16% over the last year against a 6% rise in the S&P, so far, they've been waiting for nothing.
The Motley Fool September 11, 2006 Nathan Parmelee	First Look at Martin+Osa American Eagle's Martin+Osa concept is ready to perform. Investors, take note.
The Motley Fool September 11, 2006 Brian Lawler	More Work on Cancer Drug for Genentech The FDA asks for more data about Avastin, which could be used to treat various cancers. Investors, take note.
The Motley Fool September 11, 2006 Stephen Ellis	Lampert Lights Up Sears Holdings The famed hedge fund manager wants to be the next Warren Buffett. Is he nuts or frighteningly smart? The investment thesis for Sears Holdings has to begin by considering the options currently available rather than focusing on the massive strategic missteps of years past.
The Motley Fool September 11, 2006 Rich Smith	Foolish Forecast: Wimm-Bill-Dann Is Juiced Russia's dairy king reports its second-quarter 2006 results tomorrow. Investors, take note.
The Motley Fool September 11, 2006 Rich Smith	Foolish Forecast: Energy Conversion Devices For three quarters in a row, the cutting-edge alternative energy technology company has disappointed Wall Street. Will it do so again when it reports is fiscal fourth-quarter and full-year 2006 earnings?
The Motley Fool September 11, 2006 Brian Lawler	Barr's Bidding War Barr Pharmaceuticals takes a big bite of the booming generics market. Investors, take note.
The Motley Fool September 11, 2006 Nathan Parmelee	Buying Into Panic Buying when there's panic in the streets is difficult for investors, but it's also when the rewards are largest.
The Motley Fool September 11, 2006 Jack Uldrich	IBM's Got Serious Game IBM's ability to repurpose a chip designed for high-end video games to instead simulate nuclear war games suggests that Big Blue still has some "serious game." That's why investors should remain bullish on the company as a long-term investment.
<Older 16781-16790 Newer> Return to current articles.